Freedom of Information Request – Ref: FOI 160-2026
Thank you for your recent Freedom of Information request. Please find our response below.
You asked:
1. Teledermatology provision – Does your organisation currently use a teledermatology platform or system to support the delivery of dermatology services? If yes, please confirm whether this is used for any of the following purposes:
• Store-and-forward image review
• Advice and Guidance between primary and secondary care
• Remote consultation or virtual outpatient appointments
• Triage of urgent suspected skin cancer referrals
2. Technology platform – Please state the name of the teledermatology software platform or system currently in use. If more than one platform is in use, please list all and indicate the purpose of each.
3. Commissioning and funding arrangements – Is the teledermatology platform funded and procured directly by your organisation, or is it commissioned and funded by your ICB? If both apply, please clarify which platforms fall under each arrangement. Additionally, please indicate whether any of your teledermatology platforms are funded centrally, for example through research-supported or NHS England funding.
4. Contract details – Please state the start date, end date, and total contract value of the current teledermatology platform contract or contracts, where this information is not exempt from disclosure.
5. Procurement plans – Is there an active or planned procurement for a teledermatology platform currently under way or anticipated within the next 24 months? If yes, please provide details of the anticipated timeline.
6. Dermatology referral activity – For the most recent full financial year for which data is available, please provide:
• The total number of new referrals onto a dermatology Referral to Treatment (RTT) pathway received by your organisation
• The total number of urgent suspected cancer (two-week wait) referrals for skin cancer received by your organisation
• The total number of skin cancers diagnosed by your organisation
7. Key contacts – Please provide the name and contact details, or job title if personal details are not disclosable, of the following individuals within your organisation:
• The clinical lead for dermatology
• The operational or service lead responsible for dermatology services
• The individual responsible for digital or technology procurement within dermatology or the wider clinical directorate
Our response:
The Trust does not provide the service mentioned in your request therefore we are unable to answer your questions regarding a teledermatology platform. Please re-direct your request to Gloucestershire Hospitals NHS Foundation Trust at ghn-tr.foi@nhs.net.
Next steps:
Should you have any queries in relation to our response, please do not hesitate to contact us. If you are unhappy with the response you have received in relation to your request and wish to ask us to review our response, you should write to:
Louise Moss
Head of Legal Services / Associate Director of Corporate Governance
c/o Gloucestershire Health and Care NHS Foundation Trust
Edward Jenner Court
1010 Pioneer Avenue
Gloucester Business Park
Brockworth, GL3 4AW
E-mail: louise.moss@ghc.nhs.uk
If you are not content with the outcome of any review, you may apply directly to the Information Commissioner’s Office (ICO) for further advice/guidance. Generally, the ICO will not consider your case unless you have exhausted your enquiries with the Trust which should include considering the use of the Trust’s formal complaints procedure. The ICO can be contacted at: The Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF.

